Product NDC: | 25021-782 |
Proprietary Name: | ondansetron hydrochloride |
Non Proprietary Name: | ondansetron hydrochloride |
Active Ingredient(s): | 2 mg/mL & nbsp; ondansetron hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-782 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090648 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120830 |
Package NDC: | 25021-782-20 |
Package Description: | 1 VIAL in 1 CARTON (25021-782-20) > 20 mL in 1 VIAL |
NDC Code | 25021-782-20 |
Proprietary Name | ondansetron hydrochloride |
Package Description | 1 VIAL in 1 CARTON (25021-782-20) > 20 mL in 1 VIAL |
Product NDC | 25021-782 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ondansetron hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20120830 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |